Shahida Din is a Consultant Gastroenterologist at the Western General Hospital in Edinburgh and a Research Clinician leading a scientific programme, identifying factors predictive of inflammatory bowel disease (IBD) associated colorectal cancer. In 2021, Shahida was appointed as the National IBD Surveillance lead for Scotland and is Senior author on the BSG interim framework for addressing the COVID-19-related backlog in IBD colorectal cancer surveillance. In 2022 and 2019, she was jointly awarded Helmsley Charitable Trust Grants to investigate nutritional therapy in Crohn’s Disease and develop the Crohn’s Disease Gut Cell Atlas with her collaborators in Glasgow, Edinburgh and Cambridge. Shahida is a member of the BSG IBD Committee and Gastroenterology specialty advisor to the RCPE. Shahida is passionate about patient advocacy, sharing good clinical practices and mentoring the next generation of gastroenterologists.